FDA drops longtime requirement for two clinical studies before approving new drugs, a shift that primarily affects common diseases since 60% of novel disease drugs already cleared on single trials.
1 month review for "national interest" drugs
Read the full story at The Associated Press
From the February 18, 2026 GovBrief, every story that day in one place.